Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT03201432
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 160 participants
- Sponsor
- Xiongjing Jiang
- Registry
-
NCT03201432
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03201432. Randomized; no masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2017-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
- Condition
- Ischemic Stroke
- Condition
- Vertebral Artery Stenosis
- Intervention (Device)
- Drug eluting stent (DES)
- Intervention (Device)
- Bare metal stent (BES)
- Lead sponsor
- Xiongjing Jiang
- Collaborator
- Yinyi(Liaoning) Biotech Co., Ltd.
Record details
- Record id
cardio:ct-nct03201432- Content hash
b67ce9921fb1891478338345dc850d54486c2de02110b58bb8531fc1d8e0f753